Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”

New treatment options especially of solid tumors including for metastasized prostate cancer (PCa) are urgently needed. Recent treatments of leukemias with chimeric antigen receptors (CARs) underline their impressive therapeutic potential. However CARs currently applied in the clinics cannot be repea...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Feldmann, Anja, Arndt, Claudia, Bergmann, Ralf, Loff, Simon, Cartellieri, Marc, Bachmann, Dominik, Aliperta, Roberta, Hetzenecker, Mirjam, Ludwig, Florian, Albert, Susann, Ziller-Walter, Pauline, Kegler, Alexandra, Koristka, Stefanie, Gärtner, Sebastian, Schmitz, Marc, Ehninger, Armin, Ehninger, Gerhard, Pietzsch, Jens, Steinbach, Jörg, Bachmann, Michael
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2017
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458214/
https://ncbi.nlm.nih.gov/pubmed/28404896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15572
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料